GBP4 and neoplasm: In our study, we identified GZMB, GBP4, CD79A, APOBEC3F, IDO1, JCHAIN, LAG3, PLA2G2D and XCL2 as potential tumor antigens of melanoma by multi-omics analysis, and divided melanoma into two different immune subtypes.